yariv patent's Profile

The pillow with breasts is a pillow contoured to simulate human, female breasts and utilized to provide comfort for the user by minimizing the absence of a mother or loved one. The pillow may be positioned under the neck, head, behind the shoulders, or may be placed in any position that provides...

flexible sheet has a front and a back surface. The sheet also has a top, a bottom and two sides edges. A neck hole has a lower most extent and an upper most extent. A slit is provided in a diagonal orientation. The slit extends from the lower most extent of the hole to one side edge. In this...

US 3,937,939 - Single-hand digital calculator


Abstract

An electronic digital calculator, the calculator being in the form of an elongated tubular body having a size and shape similar to a pen or pencil and having a plurality of input valve setting keys and function keys carried on its surface as well as illuminable "read-out", or display, screen. The value setting keys and the function keys are arranged on the surface of the tubular body such that the calculator can be used while held in one hand of the user.

used herein, a "targeting agent," may be any substance (such as a compound or cell) that, when linked to a modulating agent enhances the transport of the modulating agent to a target tissue, thereby increasing the local concentration of the modulating agent. Targeting agents include antibodies or fragments thereof, receptors, ligands and other molecules that bind to cells of, or in the vicinity of, the target tissue. Known targeting agents include serum hormones, antibodies against cell surface antigens, lectins, adhesion molecules, tumor cell surface binding ligands, steroids, cholesterol, lymphokines, fibrinolytic enzymes and those drugs and proteins that bind to a desired target site. Among the many monoclonal antibodies that may serve as targeting agents are anti-TAC, or other interleukin-2 receptor antibodies; 9.2.27 and NR-ML-05, reactive with the 250 kilodalton human melanoma-associated proteoglycan; and NR-LU-10, reactive with a pancarcinoma glycoprotein. An antibody targeting agent may be an intact (whole) molecule, a fragment thereof, or a functional equivalent thereof. Examples of antibody fragments are F(ab')2, -Fab', Fab and F[v] fragments, which may be produced by conventional methods or by genetic or protein engineering. Linkage is generally covalent and may be achieved by, for example, direct condensation or other reactions, or by way of bi- or multi-functional linkers.
[0143] For certain embodiments, it may be beneficial to also, or alternatively, link a drug to a modulating agent. As used herein, the term "drug" refers to any bioactive agent intended for administration to a mammal to prevent or treat a disease or other undesirable condition. Drugs include hormones, growth factors, proteins, peptides and other compounds. The use of certain specific drugs within the context of the present invention is discussed below.
[0144] Modulating agents as described herein may be present within a pharmaceutical composition. A pharmaceutical composition comprises one or more modulating agents in combination with one or more pharmaceutically or physiologically acceptable carriers, diluents or excipients. Such compositions may comprise buffers (e.g., neutral buffered saline or phosphate buffered saline), carbohydrates (e.g., glucose, mannose, sucrose or dextrans), mannitol, proteins, polypeptides or amino acids such as glycine, antioxidants, chelating agents such as EDTA or glutathione, adjuvants (e.g., aluminum hydroxide) and/or preservatives. Within yet other embodiments, compositions of the present invention may be formulated as a lyophilizate. One or more modulating agents (alone or in combination with a targeting agent and/or dr

	Abstract of WO 0183749  (A2) The present invention relates to the discovery of a gene and its sequence variation associated with preference for carbohydrates, other sweet compounds, or ethanol. The present invention also relates to the study of metabolic pathways to identify other genes, receptors, and relationships that contribute to differences in sensing of carbohydrates or ethanol. The present invention also relates to germline or somatic sequence variations and its use in the diagnosis and prognosis of predisposition to diabetes, other obesity related disorders, or ethanol consumption. The present invention also provided probes or primers specific for the detection and analysis of such sequence variation. The present invention also relates to method for screening drugs for inhibition or restoration of gene function as antidiabetic, antiobesity, or antialcohol consumption therapies.; The present invention relates to other antidiabetic, antiobesity disorder, or antialcohol consumption therapies, such as gene therapy, protein replacement therapy, etc. Finally, the present invention relates to a method for identifying sweeteners or alcohols utilizing the gene and its variations. esp@cenet — Bibliographic data on 2009-10-28 Abstract of WO 02092851  (A2) Method of determining the racing potential of a horse by measuring whether grandpaternal DNA is over-represented in the genome of the horse or, in the case where one of the grandmothers was selected for breeding on the basis of racing performance, whether grandmaternal DNA from the selected grandmother is over-represented in the genome of the horse. Data supplied from the esp@cenet database — Worldwide esp@cenet — Bibliographic data on 2009-09-01 untitled on 2009-07-27 tidases break a peptide bond in peptides by inserting a water molecule across the bond. Generally, most peptides are broken down by peptidases in the body in a manner of a few minutes or less. In addition, some peptidases are specific for certain types of peptides, making their degradation even more rapid. Thus, if a peptide is used as a therapeutic agent, its activity is generally reduced as the peptide quickly degrades in the body due to the action of peptidases. Patent Lens - Free Full-Text Patent Search: "US 7345219" on 2009-07-12 OsMAPK5a More » Groups reches 1 members, 2 items Recent Visitors (23 visits) roey rayn on 2009-11-10 ovedia nir on 2009-07-29 Diigo is about better ways to research, share and collaborate on information. Learn more » Join Diigo Me elsewhere My EasyBlog   About Diigo| Press| Help| User Forum| Blog| Tools| People Directory| Contact| Terms of Service| Privacy| © Diigo Inc 2009 Abstract of US 6224450  (B1) An activity belt to be worn by a cyclist has amusement devices attached. The amusement devices entertain a child riding in a child carrier seat behind the cyclist. The amusement devices may attach with clips so they can be changed to suit the age and interests of the child. The activity belt provides back support for the cyclist and a pocket for storing small items while cycling.   esp@cenet — Bibliographic data on 2009-08-30 Abstract of US 2009167041  (A1) A tray/cushion assembly (10) holds a drink container (13) positioned in a cup holder recess (14). Handles (16) and (17) facilitate the carrying of the cushion (10) as a tray. The tray may be an inflatable tray rolled up and housed in transport container when deflated. The container may be two parts coupled together. The assembly is used as promotional item at sporting events